The Motley Fool
21 Nov 2025, 10:20 UTC · 42w ago
Verdict
Headline leans bullish. We score TOI +0.60 across four claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.60strongly bullish
What the story claims
4 claims · scored −1 bearish … +1 bullish
The Oncology Institute reported third-quarter revenue of $137 million, representing a nearly 37% year-over-year increase.
More positive than 91% of claims this week
The company increased its full-year guidance and reaffirmed a positive outlook for Q4 adjusted EBITDA.
Continue reading
5 related stories
More positive than 75% of ticker scores this week
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 85% of claims this week
The Oncology Institute reported a net loss of $16.5 million for the third quarter, which was slightly wider than the previous year.
More negative than 80% of claims this week
The company is transitioning toward value-based care arrangements, rewarding cost-efficiency and patient outcomes over fee-for-service models.
More positive than 65% of claims this week
Which stocks this story touches
More positive than 75% of ticker scores this week
The company shows massive stock price gains, strong revenue growth, and an increased full-year guidance, despite currently operating at a net loss.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
1h ago
+58.3%
Price agrees with the score
$5.13 vs $3.24 close before publication (Nov 20) · not market-adjusted
TOI chart →
